Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GBG Forschungs is one of the world’s leading independent academic organizations dedicated to advancing breast cancer treatment. It has managed over 115 studies involving more than 70,000 patients, with ongoing collaborations in large-scale international trials such as FLAMINGO-01 for HER2-positive disease. Its work spans adjuvant/neoadjuvant therapy optimization, rare case management (e.g., pregnancy or brain metastases), prevention strategies for high-risk women, and translational research bridging basic science with clinical application[1][2][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GBG Forschungs.